Healthcare Sector Stocks
The Healthcare sector has a total of 1064 stocks, with a combined market cap of $8.14 trillion, total revenue of $4.58 trillion and a weighted average PE ratio of 40.54.
Market Cap
8.14T
Revenue
4.58T
Profits
200.78B
PE Ratio
40.54
Profit Margin
4.38%
Dividend Yield
0.43%
1064 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 845.77B | -2.72% | 3,557,691 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 532.77B | -0.53% | 5,549,658 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 356.49B | -0.57% | 4,915,515 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 345.08B | 2.77% | 6,455,081 | 449.71B |
| 5 | AZN | AstraZeneca PLC | 282.01B | 0.18% | 1,910,451 | 60.44B |
| 6 | NVS | Novartis AG | 278.19B | 0.44% | 1,067,477 | 56.58B |
| 7 | MRK | Merck & Co., Inc. | 275.09B | -0.82% | 5,725,057 | 65.77B |
| 8 | NVO | Novo Nordisk A/S | 202.73B | 0.59% | 12,054,035 | 50.57B |
| 9 | AMGN | Amgen Inc. | 179.02B | 0.79% | 2,443,210 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 172.80B | -1.99% | 3,905,768 | 45.20B |
| 11 | GILD | Gilead Sciences, Inc. | 163.11B | -2.04% | 10,250,077 | 29.74B |
| 12 | ISRG | Intuitive Surgical, Inc. | 159.39B | -0.76% | 2,402,276 | 10.58B |
| 13 | ABT | Abbott Laboratories | 146.87B | -3.09% | 10,913,578 | 45.13B |
| 14 | PFE | Pfizer Inc. | 146.36B | -1.42% | 38,902,752 | 63.32B |
| 15 | DHR | Danaher Corporation | 121.14B | -2.56% | 5,846,056 | 24.78B |
| 16 | CVS | CVS Health Corporation | 115.54B | 3.65% | 11,162,040 | 405.62B |
| 17 | BMY | Bristol-Myers Squibb Company | 114.68B | -0.16% | 10,032,436 | 48.48B |
| 18 | SYK | Stryker Corporation | 109.33B | -2.98% | 2,136,327 | 25.27B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 109.09B | 1.13% | 953,323 | 12.22B |
| 20 | SNY | Sanofi | 103.27B | 0.30% | 2,515,729 | 54.60B |
| 21 | GSK | GSK plc | 100.25B | -0.18% | 2,409,263 | 43.29B |
| 22 | MDT | Medtronic plc | 97.77B | -2.32% | 10,199,172 | 35.48B |
| 23 | HCA | HCA Healthcare, Inc. | 96.54B | 1.44% | 1,599,256 | 76.39B |
| 24 | MCK | McKesson Corporation | 88.33B | -2.47% | 2,179,530 | 403.43B |
| 25 | ELV | Elevance Health, Inc. | 82.10B | 1.38% | 1,305,885 | 200.42B |
| 26 | BSX | Boston Scientific Corporation | 80.16B | -4.67% | 20,841,203 | 20.61B |
| 27 | CI | The Cigna Group | 76.20B | 1.42% | 1,659,359 | 277.89B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 72.73B | 0.82% | 589,041 | 14.92B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 52.58B | -1.08% | 4,360,958 | 28.48B |
| 30 | MDLN | Medline Inc. | 51.92B | -5.59% | 11,853,097 | 29.14B |
| 31 | COR | Cencora, Inc. | 50.80B | 2.12% | 2,678,915 | 328.68B |
| 32 | ARGX | argenx SE | 49.10B | -0.65% | 354,305 | 4.74B |
| 33 | EW | Edwards Lifesciences Corporation | 46.04B | -3.38% | 4,031,273 | 6.30B |
| 34 | IDXX | IDEXX Laboratories, Inc. | 44.18B | -2.11% | 476,628 | 4.45B |
| 35 | CAH | Cardinal Health, Inc. | 43.01B | -0.88% | 3,260,736 | 250.74B |
| 36 | TEVA | Teva Pharmaceutical Industries Limited | 41.60B | -0.78% | 8,220,836 | 17.35B |
| 37 | BDX | Becton, Dickinson and Company | 41.17B | -2.50% | 4,481,662 | 22.23B |
| 38 | HLN | Haleon plc | 40.07B | -2.04% | 20,071,839 | 14.85B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.39B | -0.29% | 926,760 | 4.29B |
| 40 | WAT | Waters Corporation | 34.86B | 1.32% | 1,814,041 | 3.77B |
| 41 | ZTS | Zoetis Inc. | 34.72B | -5.13% | 17,182,140 | 9.53B |
| 42 | ONC | BeOne Medicines AG | 34.70B | -1.54% | 210,370 | 5.74B |
| 43 | HUM | Humana Inc. | 33.01B | 11.27% | 3,151,710 | 137.20B |
| 44 | A | Agilent Technologies, Inc. | 32.67B | -2.55% | 2,687,964 | 7.07B |
| 45 | ALC | Alcon Inc. | 30.84B | -2.07% | 4,537,504 | 10.63B |
| 46 | RVMD | Revolution Medicines, Inc. | 30.15B | -0.49% | 2,124,997 | - |
| 47 | RPRX | Royalty Pharma plc | 30.11B | 1.18% | 2,182,973 | 2.44B |
| 48 | RMD | ResMed Inc. | 29.99B | -0.06% | 993,474 | 5.54B |
| 49 | IQV | IQVIA Holdings Inc. | 29.83B | 0.04% | 1,083,074 | 16.63B |
| 50 | GEHC | GE HealthCare Technologies Inc. | 28.87B | 3.47% | 8,357,011 | 20.98B |
| 51 | BIIB | Biogen Inc. | 28.56B | 1.08% | 879,891 | 9.94B |
| 52 | NTRA | Natera, Inc. | 27.73B | -11.64% | 3,925,678 | 2.50B |
| 53 | CNC | Centene Corporation | 27.63B | 1.78% | 5,296,213 | 178.33B |
| 54 | VEEV | Veeva Systems Inc. | 27.17B | -1.14% | 2,781,320 | 3.20B |
| 55 | PHG | Koninklijke Philips N.V. | 25.91B | 0.18% | 907,822 | 20.34B |
| 56 | UTHR | United Therapeutics Corporation | 23.98B | -0.74% | 628,487 | 3.17B |
| 57 | BNTX | BioNTech SE | 23.80B | 1.19% | 1,035,527 | 3.23B |
| 58 | DXCM | DexCom, Inc. | 23.39B | -0.49% | 4,217,897 | 4.82B |
| 59 | WST | West Pharmaceutical Services, Inc. | 23.03B | 1.21% | 1,033,082 | 3.22B |
| 60 | MTD | Mettler-Toledo International Inc. | 22.77B | -14.77% | 539,256 | 4.09B |
| 61 | INSM | Insmed Incorporated | 21.97B | -3.48% | 8,587,979 | 819.56M |
| 62 | MRNA | Moderna, Inc. | 21.57B | 11.97% | 20,925,653 | 2.23B |
| 63 | ILMN | Illumina, Inc. | 21.47B | 2.29% | 1,499,443 | 4.39B |
| 64 | LH | Labcorp Holdings Inc. | 20.84B | -1.52% | 581,283 | 14.14B |
| 65 | DGX | Quest Diagnostics Incorporated | 20.74B | -1.81% | 762,516 | 11.28B |
| 66 | ROIV | Roivant Sciences Ltd. | 20.44B | 0.99% | 5,604,831 | 13.31M |
| 67 | STE | STERIS plc | 20.35B | -2.92% | 885,212 | 5.83B |
| 68 | VTRS | Viatris Inc. | 20.00B | -1.27% | 20,242,489 | 14.56B |
| 69 | INCY | Incyte Corporation | 19.69B | 0.81% | 877,675 | 5.36B |
| 70 | THC | Tenet Healthcare Corporation | 16.40B | -1.93% | 1,240,928 | 21.46B |
| 71 | ZBH | Zimmer Biomet Holdings, Inc. | 15.93B | -1.25% | 2,076,012 | 8.41B |
| 72 | GMAB | Genmab A/S | 15.88B | -2.33% | 5,919,381 | 3.90B |
| 73 | NBIX | Neurocrine Biosciences, Inc. | 15.31B | 1.78% | 1,414,972 | 3.10B |
| 74 | ASND | Ascendis Pharma A/S | 14.74B | -3.04% | 674,238 | 998.25M |
| 75 | RGC | Regencell Bioscience Holdings Limited | 14.48B | -6.96% | 96,043 | - |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 14.17B | -0.52% | 741,241 | 4.44B |
| 77 | SMMT | Summit Therapeutics Inc. | 14.03B | 5.42% | 3,878,917 | - |
| 78 | BBIO | BridgeBio Pharma, Inc. | 13.20B | -0.09% | 5,401,578 | 579.96M |
| 79 | DVA | DaVita Inc. | 12.75B | 1.22% | 1,127,110 | 13.84B |
| 80 | SNN | Smith & Nephew plc | 12.72B | -0.33% | 1,070,699 | 6.16B |
| 81 | SOLV | Solventum Corporation | 12.71B | 2.41% | 1,681,960 | 8.26B |
| 82 | GH | Guardant Health, Inc. | 12.69B | 3.73% | 3,186,780 | 1.08B |
| 83 | PEN | Penumbra, Inc. | 12.67B | -0.75% | 350,069 | 1.45B |
| 84 | IONS | Ionis Pharmaceuticals, Inc. | 12.51B | -0.41% | 1,656,232 | 1.06B |
| 85 | MEDP | Medpace Holdings, Inc. | 12.11B | -1.10% | 291,504 | 2.68B |
| 86 | EXEL | Exelixis, Inc. | 12.11B | 4.22% | 2,178,996 | 2.38B |
| 87 | ALGN | Align Technology, Inc. | 12.09B | 0.23% | 835,847 | 4.10B |
| 88 | ELAN | Elanco Animal Health Incorporated | 11.81B | -1.50% | 8,287,941 | 4.89B |
| 89 | FMS | Fresenius Medical Care AG | 11.80B | 1.76% | 1,127,680 | 22.32B |
| 90 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.76B | -4.64% | 379,297 | 1.13B |
| 91 | COO | The Cooper Companies, Inc. | 11.71B | -1.82% | 2,150,728 | 4.15B |
| 92 | RDY | Dr. Reddy's Laboratories Limited | 11.40B | -1.49% | 2,537,138 | 3.85B |
| 93 | RVTY | Revvity, Inc. | 11.29B | 2.18% | 2,441,920 | 2.90B |
| 94 | BTSG | BrightSpring Health Services, Inc. | 11.28B | 3.57% | 1,877,077 | 13.65B |
| 95 | AXSM | Axsome Therapeutics, Inc. | 11.19B | -1.29% | 574,219 | 708.24M |
| 96 | PODD | Insulet Corporation | 10.68B | -3.89% | 1,737,279 | 2.90B |
| 97 | GMED | Globus Medical, Inc. | 10.58B | -8.37% | 6,038,573 | 3.10B |
| 98 | EHC | Encompass Health Corporation | 10.53B | -0.98% | 967,634 | 6.07B |
| 99 | BMRN | BioMarin Pharmaceutical Inc. | 10.45B | -0.11% | 1,971,852 | 3.24B |
| 100 | UHS | Universal Health Services, Inc. | 10.29B | -0.35% | 1,109,717 | 17.76B |
| 101 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.18B | -6.75% | 2,700,203 | 622.01M |
| 102 | ENSG | The Ensign Group, Inc. | 9.94B | -1.64% | 704,804 | 5.27B |
| 103 | ABVX | ABIVAX Société Anonyme | 9.83B | -1.53% | 917,598 | 5.37M |
| 104 | MOH | Molina Healthcare, Inc. | 9.69B | -3.08% | 1,540,604 | 43.10B |
| 105 | CYTK | Cytokinetics, Incorporated | 9.57B | 3.53% | 5,791,775 | 105.82M |
| 106 | ICLR | ICON Public Limited Company | 9.51B | -0.41% | 681,137 | 8.10B |
| 107 | MASI | Masimo Corporation | 9.34B | -0.11% | 757,754 | 1.56B |
| 108 | BAX | Baxter International Inc. | 9.29B | 2.86% | 7,865,855 | 11.32B |
| 109 | PRAX | Praxis Precision Medicines, Inc. | 9.19B | -0.98% | 339,039 | 7.46M |
| 110 | KRYS | Krystal Biotech, Inc. | 9.01B | 3.04% | 470,580 | 417.30M |
| 111 | TEM | Tempus AI, Inc. | 8.95B | 0.79% | 11,691,015 | 1.36B |
| 112 | IBRX | ImmunityBio, Inc. | 8.91B | 9.66% | 16,203,766 | 140.98M |
| 113 | CRL | Charles River Laboratories International, Inc. | 8.56B | -2.23% | 978,194 | 4.03B |
| 114 | NUVL | Nuvalent, Inc. | 8.31B | 2.81% | 579,883 | - |
| 115 | HSIC | Henry Schein, Inc. | 8.07B | 0.42% | 1,423,006 | 13.38B |
| 116 | GKOS | Glaukos Corporation | 7.84B | -0.47% | 454,477 | 551.35M |
| 117 | ATR | AptarGroup, Inc. | 7.72B | -3.29% | 794,887 | 3.87B |
| 118 | PCVX | Vaxcyte, Inc. | 7.65B | 2.97% | 1,917,133 | - |
| 119 | HALO | Halozyme Therapeutics, Inc. | 7.60B | -1.64% | 1,650,409 | 1.40B |
| 120 | TECH | Bio-Techne Corporation | 7.57B | -5.01% | 3,736,802 | 1.21B |
| 121 | HQY | HealthEquity, Inc. | 7.17B | 1.01% | 671,101 | 1.31B |
| 122 | KYMR | Kymera Therapeutics, Inc. | 7.08B | 1.71% | 446,110 | 51.48M |
| 123 | RGEN | Repligen Corporation | 6.96B | -2.35% | 948,504 | 763.34M |
| 124 | QGEN | Qiagen N.V. | 6.83B | -1.40% | 1,657,803 | 2.10B |
| 125 | BIO | Bio-Rad Laboratories, Inc. | 6.81B | -1.17% | 230,808 | 2.59B |
| 126 | BRKR | Bruker Corporation | 6.72B | 0.98% | 2,636,871 | 3.46B |
| 127 | GRFS | Grifols, S.A. | 6.54B | 0.25% | 682,752 | 8.58B |
| 128 | MIRM | Mirum Pharmaceuticals, Inc. | 6.53B | 4.11% | 1,765,434 | 569.61M |
| 129 | HIMS | Hims & Hers Health, Inc. | 6.53B | 10.21% | 25,969,543 | 2.35B |
| 130 | SYRE | Spyre Therapeutics, Inc. | 6.52B | 2.66% | 840,579 | - |
| 131 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.45B | -2.14% | 882,543 | 217.17M |
| 132 | OSCR | Oscar Health, Inc. | 6.41B | 2.11% | 9,237,580 | 13.30B |
| 133 | PTGX | Protagonist Therapeutics, Inc. | 6.39B | 0.52% | 504,963 | 74.06M |
| 134 | CELC | Celcuity Inc. | 6.34B | 0.27% | 799,725 | - |
| 135 | APGE | Apogee Therapeutics, Inc. | 6.20B | 1.49% | 689,431 | - |
| 136 | CGON | CG Oncology, Inc. | 6.13B | 0.64% | 1,143,030 | 5.07M |
| 137 | CNTA | Centessa Pharmaceuticals plc | 6.13B | -0.04% | 682,256 | 15.00M |
| 138 | PTCT | PTC Therapeutics, Inc. | 6.11B | 14.27% | 5,836,349 | 827.11M |
| 139 | BLTE | Belite Bio, Inc | 6.09B | -0.72% | 59,969 | - |
| 140 | TGTX | TG Therapeutics, Inc. | 6.07B | -0.40% | 3,729,567 | 700.35M |
| 141 | LNTH | Lantheus Holdings, Inc. | 6.05B | 2.26% | 1,540,225 | 1.55B |
| 142 | COGT | Cogent Biosciences, Inc. | 5.94B | -0.14% | 896,097 | - |
| 143 | TFX | Teleflex Incorporated | 5.89B | 1.05% | 947,218 | 2.13B |
| 144 | IMVT | Immunovant, Inc. | 5.89B | 6.32% | 1,832,512 | - |
| 145 | ALKS | Alkermes plc | 5.83B | -1.16% | 2,596,630 | 1.56B |
| 146 | SRRK | Scholar Rock Holding Corporation | 5.77B | 4.18% | 1,048,978 | - |
| 147 | BLCO | Bausch + Lomb Corporation | 5.77B | 1.70% | 593,440 | 5.10B |
| 148 | AVTR | Avantor, Inc. | 5.67B | - | 14,978,176 | 6.55B |
| 149 | CORT | Corcept Therapeutics Incorporated | 5.61B | 2.41% | 872,672 | 769.10M |
| 150 | CHE | Chemed Corporation | 5.61B | -0.37% | 152,412 | 2.54B |
| 151 | XENE | Xenon Pharmaceuticals Inc. | 5.45B | 0.79% | 920,547 | 7.50M |
| 152 | CRSP | CRISPR Therapeutics AG | 5.29B | 4.60% | 1,733,377 | 4.10M |
| 153 | PACS | PACS Group, Inc. | 5.28B | -0.12% | 542,604 | 5.29B |
| 154 | APLS | Apellis Pharmaceuticals, Inc. | 5.25B | 0.05% | 7,067,415 | 1.11B |
| 155 | LEGN | Legend Biotech Corporation | 5.20B | -1.58% | 2,600,481 | 1.03B |
| 156 | STVN | Stevanato Group S.p.A. | 4.98B | 1.11% | 655,732 | 1.39B |
| 157 | DOCS | Doximity, Inc. | 4.80B | -0.19% | 2,075,563 | 637.78M |
| 158 | DNTH | Dianthus Therapeutics, Inc. | 4.74B | 1.45% | 517,042 | 1.34M |
| 159 | CAI | Caris Life Sciences, Inc. | 4.57B | -18.60% | 8,874,436 | 907.29M |
| 160 | RDNT | RadNet, Inc. | 4.55B | 1.20% | 1,460,456 | 2.04B |
| 161 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.51B | 2.93% | 394,278 | 754.05M |
| 162 | SHC | Sotera Health Company | 4.50B | 0.70% | 2,427,901 | 1.19B |
| 163 | NAMS | NewAmsterdam Pharma Company N.V. | 4.45B | 11.13% | 4,805,878 | 22.57M |
| 164 | LGND | Ligand Pharmaceuticals Incorporated | 4.44B | 5.27% | 249,966 | 274.48M |
| 165 | MANE | Veradermics, Incorporated | 4.37B | -1.59% | 496,309 | - |
| 166 | HNGE | Hinge Health, Inc. | 4.33B | 1.85% | 1,863,082 | 646.34M |
| 167 | BLLN | BillionToOne, Inc. | 4.28B | 0.06% | 1,300,493 | 354.54M |
| 168 | AMRX | Amneal Pharmaceuticals, Inc. | 4.21B | -3.79% | 1,519,852 | 3.05B |
| 169 | WAY | Waystar Holding Corp. | 4.10B | 1.76% | 1,897,779 | 1.16B |
| 170 | IRTC | iRhythm Holdings, Inc. | 3.97B | -3.37% | 423,137 | 787.85M |
| 171 | TVTX | Travere Therapeutics, Inc. | 3.96B | -0.14% | 2,266,003 | 536.20M |
| 172 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.95B | -13.82% | 4,814,934 | 18.07M |
| 173 | LIVN | LivaNova PLC | 3.95B | 1.31% | 901,298 | 1.43B |
| 174 | NVST | Envista Holdings Corporation | 3.94B | -0.21% | 4,873,838 | 2.81B |
| 175 | ORKA | Oruka Therapeutics, Inc. | 3.87B | 0.81% | 942,664 | - |
| 176 | ACAD | ACADIA Pharmaceuticals Inc. | 3.84B | -0.71% | 2,084,343 | 1.10B |
| 177 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.80B | -0.06% | 4,480,767 | 588.99M |
| 178 | EWTX | Edgewise Therapeutics, Inc. | 3.80B | -0.73% | 1,015,651 | - |
| 179 | LQDA | Liquidia Corporation | 3.76B | 0.05% | 1,507,823 | 158.32M |
| 180 | ALHC | Alignment Healthcare, Inc. | 3.71B | -1.75% | 3,870,044 | 4.26B |
| 181 | MMSI | Merit Medical Systems, Inc. | 3.66B | -1.70% | 469,948 | 1.54B |
| 182 | VKTX | Viking Therapeutics, Inc. | 3.64B | -0.79% | 1,448,528 | - |
| 183 | WRBY | Warby Parker Inc. | 3.63B | 8.64% | 4,177,374 | 890.57M |
| 184 | TLX | Telix Pharmaceuticals Limited | 3.62B | 0.19% | 199,028 | 803.79M |
| 185 | TWST | Twist Bioscience Corporation | 3.54B | -2.89% | 1,090,450 | 409.48M |
| 186 | OGN | Organon & Co. | 3.51B | 0.23% | 6,765,855 | 6.16B |
| 187 | TNGX | Tango Therapeutics, Inc. | 3.32B | -1.96% | 1,511,451 | 62.38M |
| 188 | MMED | MiniMed Group, Inc. | 3.25B | -1.36% | 538,388 | 2.99B |
| 189 | VCYT | Veracyte, Inc. | 3.23B | -0.83% | 1,159,335 | 541.74M |
| 190 | OPCH | Option Care Health, Inc. | 3.22B | -1.16% | 4,304,643 | 5.67B |
| 191 | BEAM | Beam Therapeutics Inc. | 3.22B | 2.70% | 2,853,187 | 164.01M |
| 192 | RCUS | Arcus Biosciences, Inc. | 3.19B | 2.34% | 967,729 | 236.00M |
| 193 | ICUI | ICU Medical, Inc. | 3.16B | 2.73% | 499,990 | 2.16B |
| 194 | ERAS | Erasca, Inc. | 3.15B | -2.69% | 3,134,619 | - |
| 195 | DNLI | Denali Therapeutics Inc. | 3.11B | -0.46% | 1,945,810 | - |
| 196 | CON | Concentra Group Holdings Parent, Inc. | 3.10B | 2.37% | 3,129,745 | 2.23B |
| 197 | BKD | Brookdale Senior Living Inc. | 3.09B | -4.28% | 5,118,214 | 3.00B |
| 198 | ALMS | Alumis Inc. | 3.01B | -0.42% | 851,843 | 24.05M |
| 199 | ITGR | Integer Holdings Corporation | 2.99B | 0.23% | 384,675 | 1.86B |
| 200 | SUPN | Supernus Pharmaceuticals, Inc. | 2.99B | -1.43% | 854,620 | 776.83M |
| 201 | LFST | LifeStance Health Group, Inc. | 2.99B | -12.99% | 24,976,010 | 1.49B |
| 202 | NHC | National HealthCare Corporation | 2.95B | 10.15% | 150,208 | 1.53B |
| 203 | DYN | Dyne Therapeutics, Inc. | 2.91B | 0.40% | 1,441,295 | - |
| 204 | PRVA | Privia Health Group, Inc. | 2.91B | -3.88% | 1,080,445 | 2.25B |
| 205 | TXG | 10x Genomics, Inc. | 2.79B | -3.66% | 4,831,624 | 638.78M |
| 206 | KLRA | Kailera Therapeutics, Inc. | 2.78B | -4.45% | 446,126 | - |
| 207 | GPCR | Structure Therapeutics Inc. | 2.78B | -0.13% | 803,106 | - |
| 208 | NKTR | Nektar Therapeutics | 2.76B | -1.78% | 722,626 | 55.63M |
| 209 | SLNO | Soleno Therapeutics, Inc. | 2.76B | - | 1,209,913 | 285.01M |
| 210 | CLDX | Celldex Therapeutics, Inc. | 2.67B | 1.95% | 794,141 | 865.00K |
| 211 | ARQT | Arcutis Biotherapeutics, Inc. | 2.65B | 2.47% | 2,714,928 | 415.62M |
| 212 | GRAL | GRAIL, Inc. | 2.65B | -2.03% | 537,755 | 156.12M |
| 213 | TARS | Tarsus Pharmaceuticals, Inc. | 2.63B | -4.30% | 1,005,125 | 535.08M |
| 214 | IRON | Disc Medicine, Inc. | 2.61B | 1.08% | 656,310 | - |
| 215 | VERA | Vera Therapeutics, Inc. | 2.60B | 0.86% | 797,425 | - |
| 216 | RARE | Ultragenyx Pharmaceutical Inc. | 2.56B | -0.04% | 1,557,057 | 670.00M |
| 217 | HAE | Haemonetics Corporation | 2.56B | 1.38% | 1,122,257 | 1.33B |
| 218 | HTFL | HeartFlow, Inc. | 2.54B | -1.57% | 541,819 | 176.03M |
| 219 | KOD | Kodiak Sciences Inc. | 2.54B | -6.11% | 721,445 | - |
| 220 | IMNM | Immunome, Inc. | 2.54B | 1.13% | 625,740 | 6.94M |
| 221 | IDYA | IDEAYA Biosciences, Inc. | 2.49B | 0.28% | 545,763 | 225.27M |
| 222 | PBH | Prestige Consumer Healthcare Inc. | 2.49B | -3.76% | 741,609 | 1.10B |
| 223 | ELVN | Enliven Therapeutics, Inc. | 2.48B | 1.14% | 606,598 | - |
| 224 | LMAT | LeMaitre Vascular, Inc. | 2.47B | 0.03% | 236,505 | 256.28M |
| 225 | RLAY | Relay Therapeutics, Inc. | 2.44B | 2.00% | 1,830,600 | 10.68M |
| 226 | MLYS | Mineralys Therapeutics, Inc. | 2.44B | 0.65% | 894,870 | - |
| 227 | DFTX | Definium Therapeutics, Inc. | 2.40B | -4.96% | 2,208,735 | - |
| 228 | TMDX | TransMedics Group, Inc. | 2.34B | -6.94% | 2,704,218 | 635.89M |
| 229 | ACHC | Acadia Healthcare Company, Inc. | 2.32B | 2.94% | 1,811,699 | 3.37B |
| 230 | GRDN | Guardian Pharmacy Services, Inc. | 2.29B | -0.50% | 542,778 | 1.46B |
| 231 | HCM | HUTCHMED (China) Limited | 2.28B | -1.05% | 16,590 | 548.51M |
| 232 | AXGN | Axogen, Inc. | 2.24B | -3.11% | 565,028 | 238.11M |
| 233 | ADPT | Adaptive Biotechnologies Corporation | 2.21B | -5.99% | 1,522,097 | 295.41M |
| 234 | XRAY | DENTSPLY SIRONA Inc. | 2.20B | 0.36% | 6,637,781 | 3.68B |
| 235 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.19B | -3.15% | 6,164,438 | 885.72M |
| 236 | BHC | Bausch Health Companies Inc. | 2.15B | 0.35% | 1,250,645 | 10.53B |
| 237 | OCUL | Ocular Therapeutix, Inc. | 2.11B | -0.31% | 2,097,014 | 52.04M |
| 238 | ESTA | Establishment Labs Holdings Inc. | 2.11B | -0.36% | 356,687 | 229.58M |
| 239 | SRPT | Sarepta Therapeutics, Inc. | 2.11B | -4.06% | 4,078,406 | 2.18B |
| 240 | NBTX | Nanobiotix S.A. | 2.11B | 6.76% | 56,597 | 38.27M |
| 241 | ZLAB | Zai Lab Limited | 2.09B | -5.92% | 1,255,208 | 453.28M |
| 242 | NVCR | NovoCure Limited | 2.07B | 6.30% | 2,376,912 | 674.41M |
| 243 | TRVI | Trevi Therapeutics, Inc. | 2.06B | 3.20% | 1,990,785 | - |
| 244 | STOK | Stoke Therapeutics, Inc. | 2.05B | 0.30% | 693,127 | 32.08M |
| 245 | TYRA | Tyra Biosciences, Inc. | 2.04B | 4.32% | 896,093 | - |
| 246 | SEM | Select Medical Holdings Corporation | 2.04B | -0.18% | 2,018,257 | 5.52B |
| 247 | AAPG | Ascentage Pharma Group International | 2.00B | -0.92% | 2,314 | 82.08M |
| 248 | SION | Sionna Therapeutics, Inc. | 2.00B | 2.12% | 405,313 | - |
| 249 | ANAB | AnaptysBio, Inc. | 1.99B | 3.49% | 462,642 | 234.60M |
| 250 | OMCL | Omnicell, Inc. | 1.99B | 1.13% | 321,091 | 1.23B |
| 251 | NEOG | Neogen Corporation | 1.97B | -2.16% | 1,596,271 | 870.56M |
| 252 | NTLA | Intellia Therapeutics, Inc. | 1.97B | 2.77% | 5,804,319 | 67.67M |
| 253 | PHVS | Pharvaris N.V. | 1.97B | 1.38% | 572,604 | - |
| 254 | INBX | Inhibrx Biosciences, Inc. | 1.96B | 7.89% | 398,129 | 1.30M |
| 255 | AUPH | Aurinia Pharmaceuticals Inc. | 1.96B | 0.59% | 1,541,826 | 298.30M |
| 256 | TSHA | Taysha Gene Therapies, Inc. | 1.96B | 2.10% | 2,179,648 | 7.47M |
| 257 | MBX | MBX Biosciences, Inc. | 1.95B | 18.02% | 1,883,087 | - |
| 258 | OCS | Oculis Holding AG | 1.93B | 4.99% | 484,933 | 1.51M |
| 259 | ASTH | Astrana Health, Inc. | 1.92B | 8.92% | 929,917 | 3.53B |
| 260 | SNDX | Syndax Pharmaceuticals, Inc. | 1.90B | 4.63% | 2,177,927 | 217.17M |
| 261 | MESO | Mesoblast Limited | 1.90B | -0.20% | 100,788 | 65.38M |
| 262 | ADMA | ADMA Biologics, Inc. | 1.89B | -3.54% | 10,208,404 | 509.86M |
| 263 | MD | Pediatrix Medical Group, Inc. | 1.89B | 2.53% | 798,764 | 1.93B |
| 264 | SGRY | Surgery Partners, Inc. | 1.87B | 0.91% | 1,262,432 | 3.34B |
| 265 | ANIP | ANI Pharmaceuticals, Inc. | 1.86B | -2.44% | 1,307,697 | 923.71M |
| 266 | PGNY | Progyny, Inc. | 1.84B | 23.80% | 4,411,517 | 1.29B |
| 267 | ADUS | Addus HomeCare Corporation | 1.82B | 2.34% | 253,776 | 1.45B |
| 268 | RAPP | Rapport Therapeutics, Inc. | 1.82B | -4.73% | 373,536 | 20.00M |
| 269 | HRMY | Harmony Biosciences Holdings, Inc. | 1.79B | -1.37% | 750,798 | 899.11M |
| 270 | SNDA | Sonida Senior Living, Inc. | 1.79B | 4.71% | 808,917 | 336.39M |
| 271 | UFPT | UFP Technologies, Inc. | 1.78B | 4.16% | 216,968 | 608.85M |
| 272 | RXRX | Recursion Pharmaceuticals, Inc. | 1.76B | 1.53% | 13,648,215 | 66.41M |
| 273 | ZYME | Zymeworks Inc. | 1.76B | -10.19% | 1,454,523 | 81.26M |
| 274 | CAPR | Capricor Therapeutics, Inc. | 1.76B | -10.49% | 3,707,722 | 11.13M |
| 275 | QURE | uniQure N.V. | 1.74B | 14.53% | 6,718,677 | 18.09M |
| 276 | GENB | Generate Biomedicines, Inc. | 1.74B | 0.52% | 291,494 | 30.30M |
| 277 | PVLA | Palvella Therapeutics, Inc. | 1.74B | 7.09% | 231,545 | - |
| 278 | VRDN | Viridian Therapeutics, Inc. | 1.71B | -2.29% | 4,372,616 | 70.92M |
| 279 | VCEL | Vericel Corporation | 1.71B | -4.75% | 1,541,571 | 292.09M |
| 280 | NRIX | Nurix Therapeutics, Inc. | 1.71B | 1.47% | 1,293,837 | 71.78M |
| 281 | AHG | Akso Health Group | 1.70B | -3.41% | 198,335 | 14.84M |
| 282 | INVA | Innoviva, Inc. | 1.69B | 0.39% | 540,341 | 420.69M |
| 283 | ARDX | Ardelyx, Inc. | 1.67B | -2.87% | 5,863,117 | 427.68M |
| 284 | NUVB | Nuvation Bio Inc. | 1.67B | -0.42% | 2,918,420 | 143.05M |
| 285 | NVAX | Novavax, Inc. | 1.66B | 9.53% | 13,354,045 | 596.34M |
| 286 | AGIO | Agios Pharmaceuticals, Inc. | 1.65B | 0.94% | 582,937 | 66.05M |
| 287 | CLOV | Clover Health Investments, Corp. | 1.64B | 10.64% | 10,388,472 | 2.21B |
| 288 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.64B | -3.09% | 1,892,369 | -665.00K |
| 289 | GLUE | Monte Rosa Therapeutics, Inc. | 1.64B | -2.12% | 547,092 | 42.95M |
| 290 | ALMR | Alamar Biosciences, Inc. | 1.63B | 1.27% | 304,575 | 74.21M |
| 291 | PAHC | Phibro Animal Health Corporation | 1.62B | -7.32% | 976,042 | 1.50B |
| 292 | PRGO | Perrigo Company plc | 1.62B | -0.09% | 2,450,626 | 4.18B |
| 293 | IOVA | Iovance Biotherapeutics, Inc. | 1.62B | 1.97% | 20,688,669 | 285.61M |
| 294 | ABCL | AbCellera Biologics Inc. | 1.60B | 8.71% | 10,843,234 | 75.13M |
| 295 | HCSG | Healthcare Services Group, Inc. | 1.58B | 3.23% | 451,888 | 1.85B |
| 296 | ENOV | Enovis Corporation | 1.53B | -2.68% | 1,537,851 | 2.28B |
| 297 | IMTX | Immatics N.V. | 1.52B | 2.06% | 376,071 | 56.67M |
| 298 | AHCO | AdaptHealth Corp. | 1.50B | -3.67% | 1,484,515 | 3.29B |
| 299 | IMCR | Immunocore Holdings plc | 1.50B | -3.40% | 130,017 | 412.81M |
| 300 | PGEN | Precigen, Inc. | 1.49B | 1.45% | 4,873,505 | 9.68M |
| 301 | BHVN | Biohaven Ltd. | 1.48B | 1.23% | 1,978,618 | - |
| 302 | BCAX | Bicara Therapeutics Inc. | 1.48B | -2.21% | 377,363 | - |
| 303 | ATAI | AtaiBeckley Inc. | 1.48B | 0.50% | 3,860,116 | 4.09M |
| 304 | VIR | Vir Biotechnology, Inc. | 1.47B | -1.62% | 1,611,671 | 65.50M |
| 305 | AVAH | Aveanna Healthcare Holdings Inc. | 1.47B | -2.88% | 927,626 | 2.43B |
| 306 | FTRE | Fortrea Holdings Inc. | 1.46B | -0.90% | 1,391,409 | 2.71B |
| 307 | DMRA | Damora Therapeutics, Inc. | 1.46B | -3.32% | 171,305 | - |
| 308 | ARDT | Ardent Health, Inc. | 1.45B | 2.12% | 385,488 | 6.43B |
| 309 | PRCT | PROCEPT BioRobotics Corporation | 1.45B | -0.16% | 1,370,324 | 322.02M |
| 310 | MAZE | Maze Therapeutics, Inc. | 1.44B | 2.20% | 534,975 | 2.50M |
| 311 | URGN | UroGen Pharma Ltd. | 1.43B | 10.57% | 1,696,635 | 140.49M |
| 312 | HROW | Harrow, Inc. | 1.42B | -2.10% | 460,173 | 272.30M |
| 313 | KALV | KalVista Pharmaceuticals, Inc. | 1.42B | 0.04% | 2,253,625 | 73.62M |
| 314 | WVE | Wave Life Sciences Ltd. | 1.38B | -0.83% | 2,550,808 | 71.80M |
| 315 | AVBP | ArriVent BioPharma, Inc. | 1.37B | 2.18% | 270,996 | - |
| 316 | CMPS | COMPASS Pathways plc | 1.34B | 5.54% | 3,537,250 | - |
| 317 | ATRC | AtriCure, Inc. | 1.33B | -5.47% | 955,645 | 552.16M |
| 318 | GHRS | GH Research PLC | 1.33B | 1.95% | 160,504 | - |
| 319 | SVRA | Savara Inc. | 1.33B | 1.36% | 816,133 | - |
| 320 | STAA | STAAR Surgical Company | 1.32B | -2.16% | 445,960 | 239.44M |
| 321 | TDOC | Teladoc Health, Inc. | 1.31B | 4.17% | 6,501,302 | 2.51B |
| 322 | CRVS | Corvus Pharmaceuticals, Inc. | 1.31B | 6.58% | 980,527 | - |
| 323 | PLSE | Pulse Biosciences, Inc. | 1.30B | -2.60% | 201,686 | 751.00K |
| 324 | OLMA | Olema Pharmaceuticals, Inc. | 1.30B | -1.52% | 592,424 | - |
| 325 | INSP | Inspire Medical Systems, Inc. | 1.28B | -2.87% | 971,767 | 915.25M |
| 326 | JBIO | Jade Biosciences, Inc. | 1.27B | 6.56% | 697,493 | - |
| 327 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.25B | 23.10% | 11,244,631 | 204.73M |
| 328 | PNTG | The Pennant Group, Inc. | 1.25B | 0.48% | 384,603 | 1.02B |
| 329 | MPLT | MapLight Therapeutics, Inc. | 1.24B | -6.16% | 292,228 | - |
| 330 | AORT | Artivion, Inc. | 1.23B | -28.26% | 5,136,852 | 458.69M |
| 331 | KMTS | Kestra Medical Technologies, Ltd. | 1.23B | -2.18% | 211,971 | 83.72M |
| 332 | COLL | Collegium Pharmaceutical, Inc. | 1.22B | -3.89% | 697,981 | 796.33M |
| 333 | MLTX | MoonLake Immunotherapeutics | 1.22B | -0.81% | 961,848 | - |
| 334 | WGS | GeneDx Holdings Corp. | 1.21B | 0.67% | 2,105,945 | 442.68M |
| 335 | DBVT | DBV Technologies S.A. | 1.19B | -1.10% | 127,428 | 5.74M |
| 336 | ZBIO | Zenas BioPharma, Inc. | 1.17B | 1.92% | 289,144 | 10.00M |
| 337 | NEO | NeoGenomics, Inc. | 1.17B | -1.21% | 1,747,900 | 745.97M |
| 338 | AVNS | Avanos Medical, Inc. | 1.16B | 0.12% | 965,890 | 715.90M |
| 339 | ATEC | Alphatec Holdings, Inc. | 1.16B | -2.97% | 5,095,611 | 787.08M |
| 340 | EYPT | EyePoint, Inc. | 1.14B | 1.86% | 661,535 | 7.61M |
| 341 | AVLN | Avalyn Pharma Inc. | 1.14B | 1.49% | 290,423 | - |
| 342 | NNNN | Anbio Biotechnology | 1.13B | -0.15% | 15,838 | 8.65M |
| 343 | XERS | Xeris Biopharma Holdings, Inc. | 1.13B | -1.51% | 3,020,195 | 314.85M |
| 344 | CDNA | CareDx, Inc. | 1.13B | 1.91% | 691,803 | 412.82M |
| 345 | AMN | AMN Healthcare Services, Inc. | 1.12B | 29.04% | 3,823,840 | 3.42B |
| 346 | IVA | Inventiva S.A. | 1.11B | 0.37% | 235,421 | 7.94M |
| 347 | COAG | Hemab Therapeutics Holdings, Inc. | 1.11B | -2.41% | 207,219 | - |
| 348 | CNMD | CONMED Corporation | 1.11B | -3.52% | 387,166 | 1.37B |
| 349 | IRMD | IRADIMED CORPORATION | 1.10B | -0.52% | 53,461 | 86.28M |
| 350 | BFLY | Butterfly Network, Inc. | 1.09B | -1.89% | 4,956,690 | 102.92M |
| 351 | MNKD | MannKind Corporation | 1.09B | -0.85% | 9,544,170 | 360.78M |
| 352 | EVO | Evotec SE | 1.08B | 0.66% | 45,569 | 925.65M |
| 353 | IART | Integra LifeSciences Holdings Corporation | 1.08B | 2.65% | 1,295,022 | 1.64B |
| 354 | BLFS | BioLife Solutions, Inc. | 1.08B | -4.52% | 722,105 | 101.66M |
| 355 | SEPN | Septerna, Inc. | 1.07B | -0.46% | 208,364 | 45.95M |
| 356 | TNDM | Tandem Diabetes Care, Inc. | 1.06B | -16.19% | 7,532,561 | 1.03B |
| 357 | AKTS | Aktis Oncology, Inc. | 1.03B | -1.27% | 117,618 | 6.50M |
| 358 | INNV | InnovAge Holding Corp. | 1.03B | -6.31% | 394,098 | 949.17M |
| 359 | ALVO | Alvotech | 1.02B | 1.87% | 469,973 | 562.04M |
| 360 | OMER | Omeros Corporation | 1.02B | -3.48% | 863,194 | - |
| 361 | LMRI | Lumexa Imaging Holdings, Inc. | 1.00B | 1.76% | 369,855 | 1.02B |
| 362 | GDRX | GoodRx Holdings, Inc. | 988.93M | 2.82% | 2,923,360 | 787.89M |
| 363 | SDGR | Schrödinger, Inc. | 981.08M | -1.13% | 1,778,280 | 254.91M |
| 364 | SANA | Sana Biotechnology, Inc. | 974.02M | 0.29% | 1,635,152 | - |
| 365 | CERT | Certara, Inc. | 967.48M | - | 4,854,395 | 418.84M |
| 366 | PHAT | Phathom Pharmaceuticals, Inc. | 965.87M | -0.57% | 628,902 | 204.89M |
| 367 | CRON | Cronos Group Inc. | 953.79M | -1.17% | 1,215,583 | 146.59M |
| 368 | XNCR | Xencor, Inc. | 953.46M | 4.47% | 899,514 | 97.36M |
| 369 | NUTX | Nutex Health Inc. | 940.40M | 1.54% | 103,927 | 879.95M |
| 370 | ANNX | Annexon, Inc. | 924.67M | 3.08% | 2,011,656 | - |
| 371 | SLS | SELLAS Life Sciences Group, Inc. | 924.51M | 1.62% | 3,435,225 | - |
| 372 | VOR | Vor Biopharma Inc. | 917.91M | 5.35% | 1,173,332 | - |
| 373 | ABSI | Absci Corporation | 917.14M | 2.61% | 7,341,561 | 1.84M |
| 374 | PHAR | Pharming Group N.V. | 916.90M | 8.17% | 19,530 | 369.49M |
| 375 | LBRX | LB Pharmaceuticals Inc | 916.76M | -0.03% | 69,601 | - |
| 376 | ORIC | ORIC Pharmaceuticals, Inc. | 916.13M | 0.45% | 1,258,115 | - |
| 377 | PCRX | Pacira BioSciences, Inc. | 910.90M | -2.07% | 513,960 | 734.86M |
| 378 | MGTX | MeiraGTx Holdings plc | 908.91M | 1.39% | 380,411 | 81.39M |
| 379 | AGL | agilon health, inc. | 904.76M | -10.60% | 860,299 | 5.82B |
| 380 | USPH | U.S. Physical Therapy, Inc. | 903.01M | 0.49% | 297,114 | 787.69M |
| 381 | CGEM | Cullinan Therapeutics, Inc. | 894.12M | -1.15% | 625,143 | - |
| 382 | GERN | Geron Corporation | 891.71M | -4.79% | 12,746,103 | 196.12M |
| 383 | DSGN | Design Therapeutics, Inc. | 888.14M | 0.85% | 402,983 | - |
| 384 | AZTA | Azenta, Inc. | 885.88M | 3.50% | 1,021,949 | 596.48M |
| 385 | INMD | InMode Ltd. | 884.49M | 0.29% | 1,384,473 | 374.64M |
| 386 | OMDA | Omada Health, Inc. | 880.53M | -9.63% | 3,233,528 | 283.30M |
| 387 | BVS | Bioventus Inc. | 877.12M | -1.41% | 360,540 | 576.30M |
| 388 | TBPH | Theravance Biopharma, Inc. | 876.92M | -0.06% | 237,594 | 109.78M |
| 389 | SPRY | ARS Pharmaceuticals, Inc. | 867.89M | -2.89% | 1,271,936 | 84.28M |
| 390 | TALK | Talkspace, Inc. | 867.12M | 0.19% | 1,119,539 | 228.87M |
| 391 | CTMX | CytomX Therapeutics, Inc. | 866.42M | -0.50% | 5,057,557 | 35.54M |
| 392 | JANX | Janux Therapeutics, Inc. | 864.13M | -2.51% | 865,755 | 13.73M |
| 393 | OPK | OPKO Health, Inc. | 860.81M | 1.79% | 1,942,105 | 581.12M |
| 394 | ABUS | Arbutus Biopharma Corporation | 854.72M | -0.23% | 752,322 | 14.08M |
| 395 | SPTX | Seaport Therapeutics, Inc. | 851.10M | 3.55% | 303,931 | - |
| 396 | ANRO | Alto Neuroscience, Inc. | 850.38M | 0.79% | 171,219 | - |
| 397 | LXRX | Lexicon Pharmaceuticals, Inc. | 847.36M | 19.05% | 7,018,734 | 69.64M |
| 398 | AMPH | Amphastar Pharmaceuticals, Inc. | 837.77M | -20.93% | 1,983,714 | 720.53M |
| 399 | KURA | Kura Oncology, Inc. | 836.14M | 1.07% | 888,923 | 67.48M |
| 400 | EVMN | Evommune, Inc. | 825.54M | 1.87% | 413,508 | 10.00M |
| 401 | ETON | Eton Pharmaceuticals, Inc. | 811.22M | -4.42% | 284,723 | 79.95M |
| 402 | ESPR | Esperion Therapeutics, Inc. | 808.25M | - | 7,428,025 | 418.24M |
| 403 | DRUG | Bright Minds Biosciences Inc. | 804.32M | -3.74% | 149,641 | - |
| 404 | BIOA | BioAge Labs, Inc. | 798.72M | 0.95% | 177,457 | 10.32M |
| 405 | ALLO | Allogene Therapeutics, Inc. | 784.27M | 0.44% | 4,476,314 | 22.00K |
| 406 | SGP | SpyGlass Pharma, Inc. | 782.52M | -7.80% | 31,481 | - |
| 407 | ODTX | Odyssey Therapeutics, Inc. | 774.60M | -8.78% | 3,171,335 | 2.98M |
| 408 | SSII | SS Innovations International, Inc. | 773.77M | -1.53% | 24,117 | 42.48M |
| 409 | RLMD | Relmada Therapeutics, Inc. | 767.78M | -1.48% | 830,480 | - |
| 410 | CBLL | CeriBell, Inc. | 765.02M | -0.93% | 307,256 | 89.06M |
| 411 | DRTS | Alpha Tau Medical Ltd. | 748.96M | 8.41% | 492,868 | - |
| 412 | QDEL | QuidelOrtho Corporation | 736.46M | 0.28% | 2,148,325 | 2.66B |
| 413 | GYRE | Gyre Therapeutics, Inc. | 724.55M | 5.66% | 52,901 | 117.05M |
| 414 | SLDB | Solid Biosciences Inc. | 715.46M | 2.83% | 924,817 | - |
| 415 | HSTM | HealthStream, Inc. | 700.00M | 1.78% | 450,983 | 311.78M |
| 416 | EHAB | Enhabit, Inc. | 699.47M | 0.15% | 584,868 | 1.06B |
| 417 | BWAY | BrainsWay Ltd. | 694.68M | 2.75% | 93,573 | 52.23M |
| 418 | IRWD | Ironwood Pharmaceuticals, Inc. | 694.67M | 1.20% | 2,552,752 | 361.51M |
| 419 | ACRS | Aclaris Therapeutics, Inc. | 688.54M | 1.44% | 1,205,716 | 8.37M |
| 420 | TENX | Tenax Therapeutics, Inc. | 686.52M | 0.09% | 929,454 | - |
| 421 | TRAX | First Tracks Biotherapeutics, Inc. | 678.99M | 9.65% | 355,109 | - |
| 422 | STRO | Sutro Biopharma, Inc. | 666.69M | 1.03% | 236,907 | 102.48M |
| 423 | TLRY | Tilray Brands, Inc. | 663.21M | -1.77% | 4,392,334 | 858.28M |
| 424 | ZVRA | Zevra Therapeutics, Inc. | 657.95M | 1.18% | 2,627,120 | 122.29M |
| 425 | ARVN | Arvinas, Inc. | 652.27M | -0.79% | 595,268 | 262.60M |
| 426 | CABA | Cabaletta Bio, Inc. | 632.63M | -3.00% | 4,663,186 | - |
| 427 | PSNL | Personalis, Inc. | 625.97M | -0.17% | 2,726,775 | 64.52M |
| 428 | CBIO | Crescent Biopharma, Inc. | 623.38M | 4.22% | 243,187 | 11.88M |
| 429 | NPCE | NeuroPace, Inc. | 622.99M | -4.87% | 329,113 | 99.99M |
| 430 | CRMD | CorMedix Inc. | 621.26M | - | 858,907 | 311.71M |
| 431 | PHR | Phreesia, Inc. | 617.96M | 3.46% | 1,274,428 | 480.59M |
| 432 | AVR | Anteris Technologies Global Corp. | 613.23M | 1.08% | 603,620 | 1.91M |
| 433 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 613.05M | -2.54% | 238,104 | - |
| 434 | CADL | Candel Therapeutics, Inc. | 611.81M | 7.19% | 2,533,536 | - |
| 435 | FBRX | Forte Biosciences, Inc. | 609.18M | -8.22% | 344,784 | - |
| 436 | CSTL | Castle Biosciences, Inc. | 601.44M | 3.07% | 498,548 | 339.92M |
| 437 | ALT | Altimmune, Inc. | 600.08M | 1.64% | 2,858,248 | 41.00K |
| 438 | AGMB | AgomAb Therapeutics NV | 597.38M | 6.22% | 107,862 | - |
| 439 | CTKB | Cytek Biosciences, Inc. | 595.35M | -6.30% | 1,361,763 | 204.17M |
| 440 | DNA | Ginkgo Bioworks Holdings, Inc. | 583.35M | -13.47% | 2,212,978 | 151.40M |
| 441 | TCMD | Tactile Systems Technology, Inc. | 578.57M | -1.38% | 385,562 | 343.52M |
| 442 | PRTA | Prothena Corporation plc | 577.63M | 2.00% | 798,769 | 57.94M |
| 443 | AVTX | Avalo Therapeutics, Inc. | 576.23M | -5.68% | 1,780,253 | 59.00K |
| 444 | PRME | Prime Medicine, Inc. | 568.63M | 3.05% | 2,446,467 | 4.03M |
| 445 | KYTX | Kyverna Therapeutics, Inc. | 565.96M | 0.54% | 461,494 | - |
| 446 | PROK | ProKidney Corp. | 561.65M | -1.06% | 719,049 | 893.00K |
| 447 | TECX | Tectonic Therapeutic, Inc. | 546.61M | 7.93% | 431,780 | - |
| 448 | RGNX | REGENXBIO Inc. | 544.56M | 1.25% | 1,379,404 | 170.44M |
| 449 | CLYM | Climb Bio, Inc. | 543.13M | -4.53% | 1,139,363 | - |
| 450 | SIBN | SI-BONE, Inc. | 542.87M | -5.25% | 725,831 | 200.93M |
| 451 | CTNM | Contineum Therapeutics, Inc. | 542.49M | -0.68% | 133,370 | - |
| 452 | AURA | Aura Biosciences, Inc. | 539.28M | 2.44% | 1,047,952 | - |
| 453 | EIKN | Eikon Therapeutics, Inc. | 539.22M | 8.62% | 567,029 | - |
| 454 | AQST | Aquestive Therapeutics, Inc. | 536.91M | 2.13% | 1,892,949 | 44.55M |
| 455 | MDXG | MiMedx Group, Inc. | 536.20M | -2.44% | 1,766,754 | 389.42M |
| 456 | VALN | Valneva SE | 535.73M | 0.54% | 22,778 | 205.07M |
| 457 | ANL | Adlai Nortye Ltd. | 531.20M | -3.07% | 227,160 | 5.00M |
| 458 | FDMT | 4D Molecular Therapeutics, Inc. | 530.07M | 2.11% | 628,015 | 88.24M |
| 459 | CERS | Cerus Corporation | 522.96M | - | 2,201,379 | 216.56M |
| 460 | STTK | Shattuck Labs, Inc. | 517.74M | 9.42% | 1,574,130 | 1.00M |
| 461 | IMMX | Immix Biopharma, Inc. | 516.87M | 2.20% | 661,183 | - |
| 462 | OCGN | Ocugen, Inc. | 511.16M | 4.86% | 10,152,531 | 4.47M |
| 463 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 5.42M |
| 464 | XOMA | XOMA Royalty Corporation | 499.15M | 1.45% | 111,706 | 52.15M |
| 465 | KMDA | Kamada Ltd. | 496.27M | 3.39% | 38,885 | 180.46M |
| 466 | UPB | Upstream Bio, Inc. | 494.68M | 1.11% | 456,143 | 2.85M |
| 467 | EBS | Emergent BioSolutions Inc. | 490.16M | 4.05% | 982,474 | 676.80M |
| 468 | OVID | Ovid Therapeutics Inc. | 484.50M | 2.56% | 1,516,126 | 7.25M |
| 469 | SRTA | Strata Critical Medical, Inc. | 481.93M | 4.31% | 823,336 | 228.58M |
| 470 | RIGL | Rigel Pharmaceuticals, Inc. | 481.79M | -0.76% | 299,364 | 299.77M |
| 471 | NGNE | Neurogene Inc. | 480.65M | -1.54% | 168,844 | 925.00K |
| 472 | SGMT | Sagimet Biosciences Inc. | 476.11M | 0.92% | 964,159 | - |
| 473 | ASMB | Assembly Biosciences, Inc. | 472.65M | -3.85% | 143,417 | 71.10M |
| 474 | WEAV | Weave Communications, Inc. | 472.62M | -1.82% | 920,280 | 248.72M |
| 475 | OFIX | Orthofix Medical Inc. | 470.91M | -3.48% | 478,179 | 825.37M |
| 476 | EVH | Evolent Health, Inc. | 470.17M | -2.11% | 2,959,838 | 1.89B |
| 477 | FULC | Fulcrum Therapeutics, Inc. | 467.10M | 1.89% | 646,137 | 80.00M |
| 478 | ANGO | AngioDynamics, Inc. | 466.84M | -0.62% | 291,099 | 313.73M |
| 479 | EPRX | Eupraxia Pharmaceuticals Inc. | 463.21M | -0.27% | 94,573 | - |
| 480 | CTEV | Claritev Corporation | 460.29M | 11.52% | 169,146 | 978.76M |
| 481 | KIDS | OrthoPediatrics Corp. | 457.45M | 1.37% | 171,007 | 243.30M |
| 482 | ZURA | Zura Bio Limited | 454.48M | 5.51% | 1,053,757 | - |
| 483 | FLGT | Fulgent Genetics, Inc. | 453.27M | 5.63% | 757,800 | 320.35M |
| 484 | LYEL | Lyell Immunopharma, Inc. | 451.02M | -3.64% | 62,013 | 31.00K |
| 485 | ADCT | ADC Therapeutics SA | 445.17M | -6.67% | 1,632,490 | 79.18M |
| 486 | ENTA | Enanta Pharmaceuticals, Inc. | 445.16M | 1.66% | 191,717 | 66.98M |
| 487 | PACB | Pacific Biosciences of California, Inc. | 437.79M | -14.55% | 9,870,271 | 160.03M |
| 488 | AVIR | Atea Pharmaceuticals, Inc. | 434.55M | -1.99% | 239,774 | - |
| 489 | LXEO | Lexeo Therapeutics, Inc. | 431.93M | 0.17% | 994,001 | - |
| 490 | BBNX | Beta Bionics, Inc. | 430.02M | -8.10% | 755,374 | 110.24M |
| 491 | VSTM | Verastem, Inc. | 429.55M | -13.60% | 7,555,450 | 49.59M |
| 492 | CATX | Perspective Therapeutics, Inc. | 428.71M | 4.44% | 794,951 | 884.00K |
| 493 | CGC | Canopy Growth Corporation | 428.41M | -1.77% | 4,533,418 | 203.04M |
| 494 | MNPR | Monopar Therapeutics Inc. | 425.45M | 1.83% | 183,343 | - |
| 495 | CCRN | Cross Country Healthcare, Inc. | 424.39M | 0.69% | 1,809,556 | 1.00B |
| 496 | IVVD | Invivyd, Inc. | 424.21M | 4.90% | 1,467,748 | 53.43M |
| 497 | NRC | NRC Health | 422.56M | 0.11% | 128,758 | 138.64M |
| 498 | PRTC | PureTech Health plc | 421.91M | 1.00% | 35,777 | 4.66M |
| 499 | BNTC | Benitec Biopharma Inc. | 420.65M | 1.15% | 169,236 | - |
| 500 | EOLS | Evolus, Inc. | 418.84M | -0.47% | 844,929 | 301.79M |